Cargando…
Usefulness of Traditional Serum Biomarkers for Management of Breast Cancer Patients
The measurement of serum tumor markers levels in breast cancer (BC) patients is an economic and noninvasive diagnostic assay frequently requested by clinical oncologists to get information about the presence or absence of disease as well as its evolution. Despite their wide use in clinical practice,...
Autores principales: | Mirabelli, Peppino, Incoronato, Mariarosaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856124/ https://www.ncbi.nlm.nih.gov/pubmed/24350285 http://dx.doi.org/10.1155/2013/685641 |
Ejemplares similares
-
CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients
por: Incoronato, Mariarosaria, et al.
Publicado: (2014) -
Radiogenomic Analysis of Oncological Data: A Technical Survey
por: Incoronato, Mariarosaria, et al.
Publicado: (2017) -
miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase
por: Orlandella, Francesca Maria, et al.
Publicado: (2020) -
The New Paradigm of Network Medicine to Analyze Breast Cancer Phenotypes
por: Grimaldi, Anna Maria, et al.
Publicado: (2020) -
KCTD15 Protein Expression in Peripheral Blood and Acute Myeloid Leukemia
por: Smaldone, Giovanni, et al.
Publicado: (2020)